Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukherji

Showing results (1081-1090 of 1,112) with videos related to

Pageof 112
Sort By:
Science Translational Medicine|October 2, 2024
A microbiome-directed therapeutic food for children recovering from severe acute malnutritionSteven J Hartman, Matthew C Hibberd, Ishita Mostafa, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent CancersYaru Xu, Zhaoning Wang, Martin Sjöström, et al.
The Laryngoscope|June 9, 2009
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionFrancis P Worden, Jeffrey Moyer, Julia S Lee, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
A microbiome-directed therapeutic food for children recovering from severe acute malnutritionSteven J Hartman, Matthew C Hibberd, Ishita Mostafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Journal of Hepatology|August 22, 2024
Targeting the liver clock improves fibrosis by restoring TGF-β signalingEmilie Crouchet, Mayssa Dachraoui, Frank Jühling, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2025
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced microsatellite stable rectal adenocarcinoma: The Averectal studyAli Shamseddine, Rim Turfa, Laudy Chehade, et al.
Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Pageof 112

Showing results (1081-1090 of 1,112) with videos related to

Sort By:
Pageof 112
Science Translational Medicine|October 2, 2024
A microbiome-directed therapeutic food for children recovering from severe acute malnutritionSteven J Hartman, Matthew C Hibberd, Ishita Mostafa, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent CancersYaru Xu, Zhaoning Wang, Martin Sjöström, et al.
The Laryngoscope|June 9, 2009
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionFrancis P Worden, Jeffrey Moyer, Julia S Lee, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
A microbiome-directed therapeutic food for children recovering from severe acute malnutritionSteven J Hartman, Matthew C Hibberd, Ishita Mostafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Journal of Hepatology|August 22, 2024
Targeting the liver clock improves fibrosis by restoring TGF-β signalingEmilie Crouchet, Mayssa Dachraoui, Frank Jühling, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2025
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced microsatellite stable rectal adenocarcinoma: The Averectal studyAli Shamseddine, Rim Turfa, Laudy Chehade, et al.
Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Pageof 112